Immunoglobulin Export Market Intelligence: India's 197 Suppliers Shipping to 119 Countries — TransData Nexus 2026

Q: Who are the top immunoglobulin exporters from India?

The top immunoglobulin exporters from India are: 1. RELIANCE LIFE SCIENCES PRIVATE LIMITED — $84.6M (47.0% market share); 2. BHARAT SERUMS AND VACCINES LIMITED — $31.8M (17.7% market share); 3. RELIANCE LIFE SCIENCES PVT LTD — $7.9M (4.4% market share); 4. LAZERHEAD LIFESCIENCES PRIVATE LIMITED — $6.3M (3.5% market share); 5. VITANE PHARMACEUTICALS PRIVATE LIMITED — $5.9M (3.3% market share). Together they account for 75.8% of India's total immunoglobulin export value.

Q: What is the total export value of immunoglobulin from India?

The total export value of immunoglobulin from India is $180.0M USD, recorded across 1,841 shipment transactions from 197 active exporters to 119 destination countries. The average shipment value is $97.8K.

Q: Which countries import immunoglobulin from India?

India exports immunoglobulin to 119 countries worldwide. The top importing countries are: SRI LANKA (15.5% share, $27.9M), UNITED ARAB EMIRATES (13.7% share, $24.7M), COLOMBIA (11.0% share, $19.8M), PERU (10.0% share, $18.0M), PHILIPPINES (9.8% share, $17.7M). These five markets account for 60.0% of total export value.

Q: What is the average price of immunoglobulin exports from India?

The average unit price for immunoglobulin exports from India is $86.09 USD per unit, with prices ranging from $0.00 to $880.70 depending on formulation, packaging, and order volume. The total market is valued at $180.0M across 1,841 shipments.

Q: Which ports handle immunoglobulin exports from India?

The primary ports for immunoglobulin exports from India are SAHAR AIR CARGO ACC (INBOM4) (29.4% of shipments), SAHAR AIR (28.1% of shipments), Bombay Air (11.4% of shipments), Bombay Air Cargo (3.4% of shipments), HYDERABAD AIR (2.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of immunoglobulin?

India is one of the world's leading exporters of immunoglobulin due to its large base of 197 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports immunoglobulin to 119 countries, demonstrating 61% global market coverage.

Q: What certifications do Indian immunoglobulin exporters need?

Indian immunoglobulin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import immunoglobulin from India?

There are 570 registered buyers importing immunoglobulin from India, spread across 119 countries. The repeat buyer rate is 48.8%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top immunoglobulin supplier from India?

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the leading immunoglobulin exporter from India with a market share of 47.0% and total export value of $84.6M across 286 shipments. The top 5 suppliers together control 75.8% of total export value.

Suresh Sormare

Immunoglobulin

India Pharmaceutical Trade Intelligence

$180.0M197 Suppliers119 CountriesHS 30021290

ExportsIndia → SRI LANKA15.5%India → UNITED ARAB13.7%

ImportsUNITED STATES → India$48.2B FRANCE → India$25.3B

#1 Supplier: RELIANCE LIFE #1 Buyer: STATE PHARMACEUTICALS

Immunoglobulin Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Immunoglobulin to the World

Between 2022 and 2026, India exported $180.0M worth of immunoglobulin across 1,841 verified shipments to 119 countries — covering 61% of world markets. The largest destination is SRI LANKA (15.5%). RELIANCE LIFE SCIENCES PRIVATE LIMITED leads with a 47.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30021290

Immunoglobulin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Immunoglobulin export data snapshot — $180.0M · 197 exporters · 119 countriesTransData Nexus · Indian Customs Data

Top Immunoglobulin Exporters from India

197 active exporters · Ranked by export value

View all 197 →

Top Immunoglobulin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$84.6M	286	27	47.0%
2	BHARAT SERUMS AND VACCINES LIMITED

Top Countries Importing Immunoglobulin from India

119 destination markets · Ranked by import value

All 119 countries →

Top Countries Importing Immunoglobulin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SRI LANKA	$27.9M	15.5%
2	UNITED ARAB EMIRATES	$24.7M	13.7%
3	COLOMBIA	$19.8M	11.0%
4	PERU	$18.0M	10.0%
5	PHILIPPINES	$17.7M	9.8%
6	CHILE	$14.4M	8.0%
7	GUATEMALA	$5.0M	2.8%
8	VIETNAM	$4.9M	2.7%
9	DOMINICAN REPUBLIC	$3.7M	2.0%
10	FRANCE	$3.4M	1.9%

SRI LANKA is India's largest immunoglobulin export destination, absorbing 15.5% of total exports worth $27.9M. The top 5 importing countries — SRI LANKA, UNITED ARAB EMIRATES, COLOMBIA, PERU, PHILIPPINES — together account for 60.0% of India's total immunoglobulin export value. The remaining 114 destination countries collectively receive the other 40.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Immunoglobulin to India?

17 origin countries · Total import value: $79.1B

India imports immunoglobulin from 17 countries with a combined import value of $79.1B. The largest supplier is UNITED STATES ($48.2B, 80 shipments), followed by FRANCE and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Immunoglobulin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$48.2B	80	60.8%
2	FRANCE	$25.3B	28	31.9%
3	GERMANY	$5.6B	162	7.1%
4	ISRAEL	$90.9M	16	0.1%
5	SWITZERLAND	$16.9M	14	0.0%
6	SOUTH KOREA	$3.9M	10	0.0%
7	ITALY	$1.5M	2	0.0%
8	CHINA	$1.3M	185	0.0%
9	SINGAPORE	$949.1K	1	0.0%
10	HUNGARY	$261.2K	1	0.0%

Showing top 10 of 17 origin countries

UNITED STATES is the largest supplier of immunoglobulin to India, accounting for 60.8% of total import value. The top 5 origin countries — UNITED STATES, FRANCE, GERMANY, ISRAEL, SWITZERLAND — together supply 100.0% of India's immunoglobulin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Immunoglobulin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Immunoglobulin products are classified as biologics by the U.S. Food and Drug Administration (FDA) and are regulated under the Biologics License Application (BLA) pathway, rather than the Abbreviated New Drug Application (ANDA) process used for generic drugs. Consequently, there are no approved ANDAs for immunoglobulin products listed in the FDA's Orange Book. The FDA maintains a list of approved immunoglobulin products, including their manufacturers and indications, on its website.

Importantly, the FDA has issued Import Alert 57-11, titled "Detention Without Physical Examination of Unlicensed Immune Globulin Intravenous (Human)," effective as of October 30, 2024. This alert mandates that foreign-manufactured, unlicensed versions of intravenous immunoglobulin (IGIV) are subject to detention without physical examination unless they possess a valid U.S. license or an accepted Investigational New Drug (IND) application. This underscores the necessity for Indian exporters to ensure compliance with FDA licensing requirements to facilitate market entry into the United States.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), immunoglobulin products require marketing authorization from the European Medicines Agency (EMA) or the UK's Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Manufacturers must adhere to Good Manufacturing Practice (GMP) standards as outlined in EU Directive 2003/94/EC. Notably, the EMA revised the European Pharmacopoeia monograph 0338 on human normal immunoglobulin, effective January 1, 2013, to address thromboembolic events associated with certain immunoglobulin preparations. This revision necessitates that manufacturers implement steps to remove thrombosis-generating agents during production. Compliance with these updated standards is essential for market approval within the EU and UK.

3WHO Essential Medicines & Global Standards

Immunoglobulin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in healthcare. Manufacturers are expected to comply with international pharmacopoeia standards, including those set forth in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards ensures product quality and facilitates acceptance in global markets.

4India Regulatory Classification

In India, immunoglobulin products are classified under Schedule H of the Drugs and Cosmetics Rules, 1945, indicating that they are prescription-only medicines. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, there is no specific ceiling price listed for immunoglobulin products. For export purposes, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The patent landscape for immunoglobulin products is complex, with various patents covering manufacturing processes, formulations, and therapeutic uses. While some patents may have expired, allowing for increased generic competition, others remain in force, potentially limiting market entry for certain products. Manufacturers must conduct thorough patent analyses to navigate potential intellectual property challenges effectively.

6Recent Industry Developments

In October 2024, the FDA issued Import Alert 57-11, emphasizing the need for foreign manufacturers to obtain proper licensing for immunoglobulin products intended for the U.S. market. This development highlights the importance of regulatory compliance for Indian exporters aiming to access the U.S. market.

Additionally, the EMA's revision of the European Pharmacopoeia monograph 0338, effective January 1, 2013, continues to influence manufacturing practices. Manufacturers are required to implement steps to remove thrombosis-generating agents during production, ensuring product safety and compliance with EU standards.

These regulatory updates underscore the dynamic nature of the immunoglobulin market and the necessity for manufacturers to stay informed and compliant with evolving standards to maintain market access and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Immunoglobulin

Retail & reference prices across 9 markets vs. India FOB export price of $86.09/unit

Global Price Benchmark for Immunoglobulin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$100–$200 per gram	USD	Pricing varies based on factors such as brand, dosage, and healthcare provider.
United Kingdom	$50–$100 per gram	GBP	According to the NHS Drug Tariff, prices are subject to periodic updates.
Germany	$75–$150 per gram	EUR	Pricing is regulated by the Federal Joint Committee (G-BA) and may vary by region.
Australia	$70–$140 per gram	AUD

Supply Chain Risk Assessment — Immunoglobulin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on imports for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of APIs and KSMs are sourced from China, underscoring a significant supply chain vulnerability. This dependency is particularly concerning for immunoglobulin production, as any disruption in the supply of these critical raw materials can impede manufacturing processes.

Recent geopolitical tensions and environmental regulations have led to the shutdown of several Chinese chemical manufacturing units, causing supply uncertainties and price volatility in APIs. Such disruptions highlight the fragility of the supply chain and the urgent need for India to bolster its domestic production capabilities to mitigate risks associated with external dependencies.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in India's immunoglobulin export market. The top five exporters account for 75.8% of total exports, with RELIANCE LIFE SCIENCES PRIVATE LIMITED alone holding a 47.0% share. This concentration poses a significant single-source risk; any operational or quality issues within these key suppliers could disrupt the entire supply chain.

To address such vulnerabilities, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at enhancing domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and Clavulanic Acid, marking a step towards reducing import dependence. However, the effectiveness of these initiatives in diversifying the supplier base for immunoglobulin remains to be seen.

Access Complete Immunoglobulin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,841 transactions across 119 markets.

Request Demo View Pricing

Frequently Asked Questions — Immunoglobulin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top immunoglobulin exporters from India?

The leading immunoglobulin exporters from India are RELIANCE LIFE SCIENCES PRIVATE LIMITED, BHARAT SERUMS AND VACCINES LIMITED, RELIANCE LIFE SCIENCES PVT LTD, and 11 others. RELIANCE LIFE SCIENCES PRIVATE LIMITED leads with 47.0% market share ($84.6M). The top 5 suppliers together control 75.8% of total export value.

What is the total export value of immunoglobulin from India?

The total export value of immunoglobulin from India is $180.0M, recorded across 1,841 shipments from 197 active exporters to 119 countries. The average shipment value is $97.8K.

Which countries import immunoglobulin from India?

India exports immunoglobulin to 119 countries. The top importing countries are SRI LANKA (15.5%), UNITED ARAB EMIRATES (13.7%), COLOMBIA (11.0%), PERU (10.0%), PHILIPPINES (9.8%), which together account for 60.0% of total export value.

What is the HS code for immunoglobulin exports from India?

The primary HS code for immunoglobulin exports from India is . This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Immunoglobulin

Immunoglobulin

Top Immunoglobulin Exporters from India

Top Countries Importing Immunoglobulin from India

Who Supplies Immunoglobulin to India?

Quick Facts

Related Products

Related Analysis

Need Details?

Regulatory Landscape — Immunoglobulin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Immunoglobulin

Supply Chain Risk Assessment — Immunoglobulin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Immunoglobulin Trade Intelligence

Frequently Asked Questions — Immunoglobulin Exports from India

Who are the top immunoglobulin exporters from India?

What is the total export value of immunoglobulin from India?

Which countries import immunoglobulin from India?

What is the HS code for immunoglobulin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of immunoglobulin exports from India?

Which ports handle immunoglobulin exports from India?

Why is India a leading exporter of immunoglobulin?

What certifications do Indian immunoglobulin exporters need?

How many buyers import immunoglobulin from India?

What is the market share of the top immunoglobulin exporter from India?

Analysis Methodology